Related Experiment Videos

Subchronic treatment increases the duration of the cognitive enhancement induced by metrifonate

M Riekkinen1, B H Schmidt, P Riekkinen

  • 1Department of Neuroscience and Neurology, University of Kuopio and Kuopio University Hospital, Finland.

Insights

Acute or chronic metrifonate treatment improved spatial learning in rats with medial septal lesions. Chronic treatment provided lasting benefits for water maze performance, unlike acute administration.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Behavioral Science

Background:

  • Medial septal lesions impair spatial navigation in rats.
  • Metrifonate is an acetylcholinesterase inhibitor with potential cognitive-enhancing effects.

Purpose of the Study:

  • To compare the efficacy of acute versus chronic metrifonate treatment on spatial learning and memory in rats with medial septal lesions.
  • To investigate the duration of metrifonate's effects on water maze performance.

Main Methods:

  • Rats with medial septal lesions were treated acutely or chronically with metrifonate.
  • Spatial learning was assessed using the water maze task, including initial acquisition and reversal learning.
  • A washout period was implemented before assessing reversal learning to evaluate the persistence of treatment effects.

Main Results:

  • Acute metrifonate administration (30 mg/kg) 30 minutes before training improved initial water maze acquisition.
  • Chronic (21-day) metrifonate pretreatment improved initial learning regardless of treatment timing.
  • While acute metrifonate's benefits were transient, subchronic treatment led to sustained improvement in reversal learning compared to controls.

Conclusions:

  • Both acute and subchronic metrifonate administration can enhance spatial learning in medial septal-lesioned rats.
  • Subchronic metrifonate treatment transforms the transient benefits of acute administration into long-lasting improvements in spatial memory.

Related Concept Videos